NYSE American - Delayed Quote USD
Serina Therapeutics, Inc. (SER)
5.84
+0.20
+(3.54%)
At close: May 13 at 3:58:10 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-19,882
-17,137
-2,476
-2,075.62
-2,250.78
Investing Cash Flow
-8
-22
-504
980.94
823.32
Financing Cash Flow
15,401
13,212
10,067
1,312.07
1,077.25
End Cash Position
4,267
3,672
7,619
532.23
314.85
Interest Paid Supplemental Data
--
--
--
15.88
3.09
Capital Expenditure
--
-22
-504
-9.68
-108.43
Issuance of Capital Stock
9,916
5,000
0
4.42
90.15
Issuance of Debt
643
3,043
10,100
5,000
0
Repayment of Debt
-155
-168
-48
-3,692.35
-12.91
Free Cash Flow
-19,890
-17,159
-2,980
-2,085.31
-2,359.21
12/31/2021 - 11/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INTS Intensity Therapeutics, Inc.
0.5175
-3.47%
LCTX Lineage Cell Therapeutics, Inc.
0.4700
-1.90%
TYRA Tyra Biosciences, Inc.
9.98
-2.73%
DSGN Design Therapeutics, Inc.
3.5700
-1.38%
GYRE Gyre Therapeutics, Inc.
11.50
+6.19%
2257.HK Sirnaomics Ltd.
2.980
-3.87%
ARTV Artiva Biotherapeutics, Inc.
2.0500
-2.38%
BTTX Better Therapeutics, Inc.
0.0003
+50.00%
ATHXQ Athersys, Inc.
0.0000
0.00%
FYB.DE Formycon AG
23.90
+3.24%